KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Taxes (2016 - 2022)

Fulgent Genetics' Current Taxes history spans 6 years, with the latest figure at $426000.0 for Q3 2022.

  • On a quarterly basis, Current Taxes fell 97.62% to $426000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $426000.0, a 97.62% decrease, with the full-year FY2021 number at $787000.0, down 98.52% from a year prior.
  • Current Taxes hit $426000.0 in Q3 2022 for Fulgent Genetics, down from $2.8 million in the prior quarter.
  • Over the last five years, Current Taxes for FLGT hit a ceiling of $120.5 million in Q1 2021 and a floor of $24000.0 in Q4 2019.
  • Historically, Current Taxes has averaged $24.1 million across 4 years, with a median of $8.7 million in 2020.
  • Biggest five-year swings in Current Taxes: skyrocketed 222062.5% in 2020 and later crashed 98.52% in 2021.
  • Tracing FLGT's Current Taxes over 4 years: stood at $24000.0 in 2019, then skyrocketed by 222062.5% to $53.3 million in 2020, then tumbled by 98.52% to $787000.0 in 2021, then crashed by 45.87% to $426000.0 in 2022.
  • Business Quant data shows Current Taxes for FLGT at $426000.0 in Q3 2022, $2.8 million in Q2 2022, and $52.2 million in Q1 2022.